Bronchodilators

Links shared publicly online about this topic

Bronchodilators - What Are Bronchodilators Video - About.com

video.about.com — “When bronchi are constricted mucus levels increase. Bronchodilators are medications that treat constricted bronchi.View full resource at video.about.com

  • View Related
  • Share

Most Recently Shared on May 14, 2010 at 3:26 am By:

guideasthma Pat Physician, Doctor, Pediatrician, and Internist

What Are Bronchodilators? Check Out This Video That Shows How Your Rescue Inhaler Works http://cli.gs/MgMXXV

2 years ago...

Maternal bronchodilator use and the risk of orofacial clefts

humrep.oxfordjournals.org — “Maternal bronchodilator use and the risk of orofacial cleftsView full resource at humrep.oxfordjournals.org

  • View Related
  • Share

Most Recently Shared on September 22, 2011 at 12:05 pm By:

JuanCIvancevich Juan C. Ivancevich, MD Doctor, Internist, Allergist, and Physician

Association between maternal bronchodilator use during the periconceptional period and the risk of cleft lip http://t.co/dW2gYpHp

5 months ago...

Pediatrics Medical News about bronchodilator response

mdlinx.com — “An elevated bronchodilator response predicts large airway inflammation in mild asthmaView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on January 22, 2010 at 10:29 am By:

MDLinx Sandeep Pulim MD Physician, Doctor, and Health Communicator

Peds: An elevated bronchodilator response predicts large airway inflammation in mild asthma: Pediatric Pulmonology http://url4.eu/1BwGN

2 years ago...

Bronchodilation in asthmatics maintained with daily dosing of RPL554 - Drugs.com MedNews

drugs.com — “Highlights Identical bronchodilator responses seen after 1, 3 and 6 days of treatment No evidence of RPL554 accumulation in plasma over 6 days There were no safView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on August 23, 2011 at 7:14 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Bronchodilation in asthmatics maintained with daily dosing of RPL554: Highlights • Identical bronchodilato... http://t.co/9zbiDF1 #drug

6 months ago...

Leading Patient Education Organization To Asthma Patients: Talk To Your Healthcare Provider About FDA 12-Hour Bronchodilator Warnings

medicalnewstoday.com — “Allergy & Asthma Network Mothers of Asthmatics (AANMA) encourages patients to make informed decisions about recent U.S. Food and Drug Administration (FDA) recommendations affecting patients usingView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 3, 2010 at 5:08 pm By:

mnt_asthma MNT Asthma News Health News

Leading Patient Education Organization To Asthma Patients: Talk To Your Healthcare Provider About FDA 12-Hour Bronchod... http://mnt.to/3ypd

2 years ago...

Emergency Medicine Article | Effects of Nebulized Bronchodilator Therapy on Heart Rate and Arrhythmias in Critically Ill Adult Patients

mdlinx.com — “Effects of Nebulized Bronchodilator Therapy on Heart Rate and Arrhythmias in Critically Ill Adult PatientsView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on October 6, 2011 at 10:22 pm By:

MDLinx Sandeep Pulim MD Physician, Doctor, and Health Communicator

Effects of Nebulized Bronchodilator Therapy on Heart Rate and Arrhythmias in Critically Ill Adult Patients: Chest http://t.co/HPRywJQf #ER

4 months ago...

LABA Bronchodilator for Asthma - Long Acting Beta Agonist Provide Asthma Symptom Control

asthma.about.com — “LABA bronchodilators can be an important part of your asthma care plan, but there are some safety concerns you need to be aware of. Learn what you need to know about LABAs.View full resource at asthma.about.com

  • View Related
  • Share

Most Recently Shared on September 13, 2010 at 6:54 pm By:

guideasthma Pat Physician, Doctor, Pediatrician, and Internist

LABA Bronchodilator for Asthma - Long Acting Beta Agonist Provide Asthma Symptom Control - http://bit.ly/a41GG3

1 year ago...

Nursing Medical News about Administration, Inhalation Bronchodilator Agents Pulmonary Disease, Chronic Obstructive Adrenal Cortex Hormones

mdlinx.com — “Mono- and Combination Therapy of Long-Acting Bronchodilators and Inhaled Corticosteroids in Advanced COPDView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on May 30, 2010 at 7:08 am By:

MDLinx Sandeep Pulim MD Physician, Doctor, and Health Communicator

Mono- and Combination Therapy of Long-Acting Bronchodilators and Inhaled Corticosteroids in Advanced COPD:... http://bit.ly/ad1ajQ #Nursing

2 years ago...

FDA advisory committee recommends US approval of Novartis once-daily bronchodilator QAB149 for COPD

novartis.com — “FDA advisory committee recommends US approval of Novartis once-daily bronchodilator QAB149 for COPDView full resource at novartis.com

  • View Related
  • Share

Most Recently Shared on March 9, 2011 at 2:40 pm By:

eyeonfda eyeonfda Health Lawyer and Pharma

FDA advisory committee recommends US approval of Novartis once-daily bronchodilator QAB149 for COPD - http://ow.ly/4aQ4K

11 months ago...

FDA Approves Once-Daily Bronchodilator for COPD - QualityPoint Technologies

qualitypointtech.net — “As a once-a-day drug, the new long-acting beta2-adrenergic agonist promises greater patient adherence than twice-daily LABAs. Medscape Medical NewsView full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on July 2, 2011 at 12:45 am By:

MedicalFeed MedicalFeed Health News Feed

FDA Approves Once-Daily Bronchodilator for COPD: As a once-a-day drug, the new long-acting beta2-adrenergic agonis... http://bit.ly/kUOvxK

7 months ago...

LABA Bronchodilator for Asthma - Long Acting Beta Agonist Provide Asthma Symptom Control

asthma.about.com — “LABA bronchodilators can be an important part of your asthma care plan, but there are some safety concerns you need to be aware of. Learn what you need to know about LABAs.View full resource at asthma.about.com

  • View Related
  • Share

Most Recently Shared on October 10, 2011 at 8:37 pm By:

guideasthma Pat Physician, Doctor, Pediatrician, and Internist

What You Need To Know About Your LABA-- Risks, Benefits & Side Effects http://t.co/PRfAMRml

4 months ago...

Novartis receives approval in the European Union for Onbrez Breezhaler, a new once-daily bronchodilator for patients with COPD

novartis.com — “Basel, December 3, 2009 - Novartis announced today that the European Commission (EC) has approved Onbrez Breezhaler (QAB149 or indacaterol) in both 150 mcg and 300 mcg doses as a new once-daily maintenance bronchodilator treatment of airflow obstruction in adult patients with chronic obstructive pulmonary disease (COPD).View full resource at novartis.com

  • View Related
  • Share

Most Recently Shared on December 3, 2009 at 1:40 pm By:

eyeonfda eyeonfda Health Lawyer and Pharma

Novartis gets EU approval for new COPD treatment - http://ow.ly/Ias3

2 years ago...

PharmaLive: Novartis Receives FDA Approval for Arcapta Neohaler, A Novel Once-Daily Bronchodilator for Chronic Obstructive Pulmonary Disease

pharmalive.com — “PharmaLive: Novartis Receives FDA Approval for Arcapta Neohaler, A Novel Once-Daily Bronchodilator for Chronic Obstructive Pulmonary DiseaseView full resource at pharmalive.com

  • View Related
  • Share

Most Recently Shared on July 5, 2011 at 6:20 pm By:

pharmalive PharmaLive Pharma and Health News

Daily Advantage - FDA OKs Novartis COPD Bronchodilator - http://tinyurl.com/3olyl92

7 months ago...

Phase III data show Novartis investigational bronchodilator QAB149 significantly improves lung function over current treatments in COPD[1],[2]

novartis.com — “Basel, May 21, 2009 - Initial results from three pivotal phase III trials show the Novartis investigational bronchodilator QAB149 (indacaterol) could deliver clinically relevant* lung function improvements, within five minutes of the first dose, lasting for 24 hours in patients with chronic obstructive pulmonary disease (COPD)[3],[4],[5].View full resource at novartis.com

  • View Related
  • Share

Most Recently Shared on May 21, 2009 at 5:37 am By:

Novartis Novartis Pharma

Phase III data show Novartis investigational bronchodilator QAB149 significantly improves lung function over cur.. http://twurl.nl/456hie

3 years ago...

FDA informs Novartis of extension to US regulatory review period for QAB149, a novel once-daily bronchodilator for treatment of COPD

novartis.com — “FDA informs Novartis of extension to US regulatory review period for QAB149, a novel once-daily bronchodilator for treatment of COPDView full resource at novartis.com

  • View Related
  • Share

Most Recently Shared on March 23, 2011 at 3:24 pm By:

eyeonfda eyeonfda Health Lawyer and Pharma

#FDA extends regulatory review period for Novartis #COPD drug http://ow.ly/4kMob

11 months ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related WisdomCards

Featuring the top 3 experts for this topic

  • guideasthma

    Pat

    I am the about.com guide to asthma. Asthma news and information.

    View Profile

  • JuanCIvancevich

    Juan C. Ivancevich, MD

    Allergist - Head Allergy & Immunology, Santa Isabel Clinic, Buenos Aires. Assistant Professor of Immunology, Medicine School, Universidad del Salvador, Buenos Aires. Member of the Board of Directors, World Allergy Organization. President of the South Cone Chapter on the Latin American Society of Allergy, Asthma & Immunology.

    View Profile

  • MDLinx

    Sandeep Pulim MD

    Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390